Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flaherty

Showing results (71-80 of 714) with videos related to

Pageof 72
Sort By:
Expert Reviews in Molecular Medicine|October 13, 2012
MEK and RAF inhibitors for BRAF-mutated cancersSarah Belden, Keith T Flaherty
Journal of Travel Medicine|September 8, 2021
The advent of social media influencer tourism: travel health risks and opportunitiesRyan M Mangan, Gerard T Flaherty
Annals of Internal Medicine|August 4, 2018
When Tissue Is No Longer the Issue: Tissue-Agnostic Cancer Therapy Comes of AgeShiuh-Wen Luoh, Keith T Flaherty
Journal of Travel Medicine|April 20, 2018
High altitude travel and mental healthGerard T Flaherty, Chen Wei Chua
International Health|March 25, 2022
Transportation of therapeutic and controlled drugs across international borders: a descriptive analysis of information available to travellersJack R Kissane, Gerard T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2012
BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistanceAlexander Marzuka Alcalá, Keith T Flaherty
Trends in Cancer|July 26, 2017
Biomarkers in Melanoma: Lessons from Translational MedicineElizabeth I Buchbinder, Keith T Flaherty
Nature Reviews. Clinical Oncology|November 29, 2017
Melanoma in 2017: Moving treatments earlier to move further forwardsMichael A Davies, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2017
<i>AACR Cancer Progress Report 2017:</i> Harnessing Research Discoveries to Save LivesMarlowe S Tessmer, Keith T Flaherty
Cardiology Clinics|February 1, 1991
Medical therapy of unstable angina pectorisS O Gottlieb, J T Flaherty
Pageof 72

Showing results (71-80 of 714) with videos related to

Sort By:
Pageof 72
Expert Reviews in Molecular Medicine|October 13, 2012
MEK and RAF inhibitors for BRAF-mutated cancersSarah Belden, Keith T Flaherty
Journal of Travel Medicine|September 8, 2021
The advent of social media influencer tourism: travel health risks and opportunitiesRyan M Mangan, Gerard T Flaherty
Annals of Internal Medicine|August 4, 2018
When Tissue Is No Longer the Issue: Tissue-Agnostic Cancer Therapy Comes of AgeShiuh-Wen Luoh, Keith T Flaherty
Journal of Travel Medicine|April 20, 2018
High altitude travel and mental healthGerard T Flaherty, Chen Wei Chua
International Health|March 25, 2022
Transportation of therapeutic and controlled drugs across international borders: a descriptive analysis of information available to travellersJack R Kissane, Gerard T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2012
BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistanceAlexander Marzuka Alcalá, Keith T Flaherty
Trends in Cancer|July 26, 2017
Biomarkers in Melanoma: Lessons from Translational MedicineElizabeth I Buchbinder, Keith T Flaherty
Nature Reviews. Clinical Oncology|November 29, 2017
Melanoma in 2017: Moving treatments earlier to move further forwardsMichael A Davies, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2017
<i>AACR Cancer Progress Report 2017:</i> Harnessing Research Discoveries to Save LivesMarlowe S Tessmer, Keith T Flaherty
Cardiology Clinics|February 1, 1991
Medical therapy of unstable angina pectorisS O Gottlieb, J T Flaherty
Pageof 72